Soy-Derived Antihypertensive Peptide
Functional peptides
Product Overview
A soy-derived functional peptide product for research and food formulation studies related to blood-pressure management.
Reference price: ¥200 / kg
Technical Overview
Soy protein is processed by targeted enzymatic hydrolysis and refinement to produce predominantly small peptides. The product document discusses in-vitro ACE-inhibition research and reports observations from an SHR animal model.
The material is intended for formulation and research. Animal or in-vitro results should not be interpreted as demonstrated clinical efficacy in humans.
Specifications
- Soy-derived
- Peptides predominantly below 3 kDa
- In-vitro ACE-inhibition research
- Observed in SHR animal study: systolic pressure −16 mmHg and diastolic pressure −9 mmHg
Applications
- Functional oral liquids
- Soy beverages
- Protein tablets
- Cardiovascular-health food research
Product Features
- Plant-derived soy protein
- Produced by targeted enzymatic hydrolysis
- Small peptides
- Suitable for related functional-food formulation research
Source and Storage
- Storage
- Store sealed and protected from light; follow the final product label and technical documents.
Patent Application
Preparation and Use of Soy Oligopeptides for Hypertension-Related Research
Related invention patent application No. 202610297654.8 entered substantive examination on 2026-05-08. This does not mean the patent has been granted or the product certified.
Frequently Asked Questions
What is distinctive about the peptide-production enzyme?
The source describes a proprietary enzyme approach for producing soy peptides with ACE-inhibitory activity, with potential application in food and pharmaceutical research.
What are the advantages of the soy-peptide approach?
Targeted hydrolysis releases peptides of interest. The source cites an SHR animal-model observation of systolic pressure decreasing by 16 mmHg and diastolic pressure by 9 mmHg, and related publications. These are research observations, not a clinical efficacy claim.
What product formats are possible?
The source mentions soy beverages and protein tablets among possible formats. Final safety, efficacy and health claims require product-specific evaluation and applicable regulatory approval.
Technical Inquiry
For batch-specific specifications, storage conditions, suitability and application guidance, contact our team with your target substrate and use case.
Contact us →